Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma
Citation
Gurnell , M , Domingo , C , Rabe , K F , Menzies-Gow , A , Price , D , Brusselle , G , Wechsler , M E , Xia , C , Pandit-Abid , N , Gall , R , Jacob-Nara , J A , Rowe , P J , Deniz , Y & Siddiqui , S 2022 , ' Dupilumab reduces OCS use and improves lung function in patients with severe OCS-dependent asthma ' , European Respiratory Society (ERS) International Congress. , Barcelona , Spain , 4/09/22 - 6/09/22 . conference